Health and Fitness Health and Fitness
Thu, January 13, 2011
[ Thu, Jan 13th 2011 ] - Market Wire
Winter Weather Spells SAD for Some
[ Thu, Jan 13th 2011 ] - Market Wire
St. Jude Medical Announces Launch of the ViewMate .. Ultrasound System and ViewFlex Plus ICE Catheter
[ Thu, Jan 13th 2011 ] - Market Wire
Codexis to Announce Fourth Quarter 2010 Financial Results on February 3, 2011
[ Thu, Jan 13th 2011 ] - Market Wire
ADVISORY - Nordion to Release Fourth Quarter 2010 and Year-end Financial Results
[ Thu, Jan 13th 2011 ] - Market Wire
International Stem Cell Applauds Research Showing .. Potential Strategy for Treating Inherited Disease
[ Thu, Jan 13th 2011 ] - Market Wire
Obagi Medical Products Introduces Blue Peel RADIANCE and Nu-Derm Sun Shield SPF 50
[ Thu, Jan 13th 2011 ] - Market Wire
BioCryst Announces Peramivir Phase 3 Safety & Vir .. dy Results and Provides a Clinical Program Update
Wed, January 12, 2011
[ Wed, Jan 12th 2011 ] - Market Wire
Intuitive Surgical, Inc. Fourth Quarter and Year-End 2010 Earnings Conference Call
[ Wed, Jan 12th 2011 ] - Market Wire
CENTRIC HEALTH ANNOUNCES COURT APPROVAL OBTAINED ON ACQUISITION OF DEDICATED PHARMACY GROUP
[ Wed, Jan 12th 2011 ] - Market Wire
Last Days for North American Companies to Registe .. ings. Registration period ends on Friday, January
[ Wed, Jan 12th 2011 ] - Market Wire
Sanofi-aventis Enters Into Two Research & Develop .. With the University of California, San Francisco
[ Wed, Jan 12th 2011 ] - Market Wire
FDA Awards SDIX Method Equivalency for Salmonella Enteritidis Detection in Poultry Houses and Eggs
[ Wed, Jan 12th 2011 ] - Market Wire
MedImmune and Micromet Announce Initiation of Pha .. tibody MEDI-565 (MT111) in Patients with Advanced
[ Wed, Jan 12th 2011 ] - Market Wire
CytRx Raises $7 Million from Sale of Remaining Equity Interest in RXi Pharmaceuticals
[ Wed, Jan 12th 2011 ] - Market Wire
St. Jude Medical Announces Preliminary Fourth Quarter Revenue Results
[ Wed, Jan 12th 2011 ] - Market Wire
Wright Medical Group, Inc. Announces Launch of DARCO® Foot & Ankle Plating Line in Japan
[ Wed, Jan 12th 2011 ] - Market Wire
DSM and Codexis Sign Enzyme Supply Agreement
[ Wed, Jan 12th 2011 ] - Market Wire
Merck and PAREXEL Form Strategic Alliance Focused on Clinical Development of Biosimilar Candidates
[ Wed, Jan 12th 2011 ] - Market Wire
Salix Pharmaceuticals, Inc. and the Colon Cancer .. For Dummies® is Now Available for Free Download
[ Wed, Jan 12th 2011 ] - Market Wire
CIRC (Circulation Improving Resuscitation Care) Trial Concludes Successfully
[ Wed, Jan 12th 2011 ] - Market Wire
Biogen Idec geeft update over het bedrijf op beleggersbijeenkomst
[ Wed, Jan 12th 2011 ] - Market Wire
Biogen Idec proporciona informacin actualizada sobre el negocio durante reunin de inversores
[ Wed, Jan 12th 2011 ] - Market Wire
Biogen Idec fournit un bilan de son activit© lors d'une r©union avec les investisseurs
[ Wed, Jan 12th 2011 ] - Market Wire
Santarus to Webcast Analyst Day and Investor Briefing Presentation on January 19
Tue, January 11, 2011
[ Tue, Jan 11th 2011 ] - Market Wire
Dr. Reddy's to Release Q3 FY11 Results on January 25, 2011
[ Tue, Jan 11th 2011 ] - Market Wire
Biogen Idec legt aktuelle Geschftsinformationen auf Investorenkonferenz vor
[ Tue, Jan 11th 2011 ] - Market Wire
Illumina Acquires Epicentre Biotechnologies, Lead .. Sample Preparation Reagents and Specialty Enzymes
[ Tue, Jan 11th 2011 ] - Market Wire
Illumina Announces MiSeqa" Personal Sequencing System
[ Tue, Jan 11th 2011 ] - Market Wire
Illumina Announces Preliminary Financial Results for Fourth Quarter 2010
[ Tue, Jan 11th 2011 ] - Market Wire
Biogen Idec fornisce un aggiornamento sul business durante la riunione degli investitori

Biogen Idec fornisce un aggiornamento sul business durante la riunione degli investitori


Published on 2011-01-11 16:06:13 - Market Wire
  Print publication without navigation


SAN FRANCISCO--([ BUSINESS WIRE ])--Nella presentazione agli investitori di oggi durante la 29a Conferenza annuale sulla sanit J. P. Morgan, il CEO di [ Biogen Idec ] (NASDAQ: BIIB), George Scangos, Ph.D., descriver il progresso della societ relativo alla sua struttura per la crescita, e parler in dettaglio delle milestone previste per il 2011 e gli anni successivi. Il dott. Scangos terr il suo discorso oggi alle 15:30 (PST, ora standard del Pacifico). Il suo discorso e la corrispondenti diapositive illustrative saranno disponibili con trasmissione via Internet sulla sezione per le relazioni con gli investitori del sito [ www.biogenidec.com ].

"I fondamentali aziendali di Biogen Idec sono forti a" e stiamo costruendo a partire da questi punti di forza per trasformare la societ nel 2011 e negli anni successivi"

aI fondamentali aziendali di Biogen Idec sono forti a" e stiamo costruendo a partire da questi punti di forza per trasformare la societ nel 2011 e negli anni successivia, ha detto il dott. Scangos.

Il testo originale del presente annuncio, redatto nella lingua di partenza, la versione ufficiale che fa fede. Le traduzioni sono offerte unicamente per comodit del lettore e devono rinviare al testo in lingua originale, che l'unico giuridicamente valido.

Contributing Sources